An AICD-dependant mechanism could also be the target of the NMDAR-GluN2B antagonist memantine (Xia et al., 2010) commonly used for more than a decade to prevent declines in cognition, behavior and autonomy in AD patients, albeit with modest efficacy (Matsunaga et al., 2015). The gene discussed is GRIN2B; the disease is Alzheimer disease.